Technology
Health
Biotechnology

Scholar Rock

$12.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.29 (-2.21%) As of 12:10 PM EDT today
-$0.29 (-2.21%) Today

Why Robinhood?

You can buy or sell Scholar Rock and other stocks, options, ETFs, and crypto commission-free!

About SRRK

Scholar Rock Holding Corporation Common Stock, also called Scholar Rock, is a biopharmaceutical company, which engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Read More Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Employees
65
Headquarters
Cambridge, Massachusetts
Founded
2012
Market Cap
344.76M
Price-Earnings Ratio
Dividend Yield
Average Volume
130.29K
High Today
$13.23
Low Today
$12.64
Open Price
$13.23
Volume
49.60K
52 Week High
$30.00
52 Week Low
$12.64

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2018 IPO
US
North America

SRRK Earnings

-$1.39
-$1.07
-$0.74
-$0.42
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.